Athersys (ATHX) Stock Forecast, Price Target & Predictions

ATHX Stock Forecast

Athersys stock forecast is as follows: a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.

ATHX Analyst Ratings

Buy

According to 10 Wall Street analysts, Athersys's rating consensus is 'Buy'. The analyst rating breakdown for ATHX stock is 0 'Strong Buy' (0.00%), 9 'Buy' (90.00%), 1 'Hold' (10.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Mar 06, 2023	Goldman Sachs	-	Buy	Initialise
Mar 06, 2023	Alliance Global Partners	-	Buy	Initialise
Mar 06, 2023	Credit Suisse	-	Outperform	Initialise
Mar 06, 2023	Roth Capital	-	Buy	Initialise
Mar 06, 2023	Scotiabank	-	Sector Outperform	Initialise
Mar 06, 2023	Jefferies	-	Hold	Initialise
Mar 06, 2023	Citigroup	-	Overweight	Initialise
Mar 06, 2023	Ascendiant	-	Buy	Initialise
Mar 06, 2023	Barclays	-	Overweight	Initialise
Mar 06, 2023	Piper Sandler	-	Overweight	Initialise

Row per page

Go to

Athersys's last stock rating was published by Goldman Sachs on Mar 06, 2023. The company Initialise its ATHX rating from "null" to "Buy".

Athersys Financial Forecast

Athersys Revenue Forecast

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Mar 18	Sep 17	Jun 17	Mar 17	Sep 16	Jun 16	Mar 16	Sep 15	Jun 15
Revenue	-	-	-	-	-	$49.00K	-	$65.00K	$2.32M	$2.91M	$5.51M	$4.79K	-	-	$86.00K	$84.00K	-	$-361.00K	$4.26M	$1.45M	$2.32M	$1.07M	$399.00K	$669.00K	$1.47M	$311.00K	$595.00K	$15.46M	$396.00K	$216.00K
Avg Forecast	$110.25K	$98.00K	$85.75K	$73.50K	$61.25K	$49.00K	$120.00K	$44.00K	$37.40K	$3.20M	$40.00K	$40.00K	$40.00K	$420.00K	$66.89K	$67.20K	$382.67K	$406.13K	$6.39M	$1.12M	$2.32M	$1.07M	$400.00K	$781.67K	$1.72M	$398.57K	$750.00K	$20.61M	$350.00K	$1.54M
High Forecast	$110.25K	$98.00K	$85.75K	$73.50K	$61.25K	$49.00K	$120.00K	$52.80K	$44.88K	$3.20M	$40.00K	$48.00K	$40.00K	$420.00K	$66.89K	$67.20K	$382.67K	$406.13K	$6.39M	$1.12M	$2.32M	$1.07M	$400.00K	$781.67K	$1.72M	$398.57K	$750.00K	$20.61M	$350.00K	$1.54M
Low Forecast	$110.25K	$98.00K	$85.75K	$73.50K	$61.25K	$49.00K	$120.00K	$35.20K	$29.92K	$3.20M	$40.00K	$32.00K	$40.00K	$420.00K	$66.89K	$67.20K	$382.67K	$406.13K	$6.39M	$1.12M	$2.32M	$1.07M	$400.00K	$781.67K	$1.72M	$398.57K	$750.00K	$20.61M	$350.00K	$1.54M
# Analysts	7	6	6	6	6	13	6	13	20	9	9	10	9	9	9	9	9	8	8	8	9	9	9	9	9	8	8	8	9	9
Surprise %	-	-	-	-	-	1.00%	-	1.48%	61.93%	0.91%	137.73%	0.12%	-	-	1.29%	1.25%	-	-0.89%	0.67%	1.29%	1.00%	1.00%	1.00%	0.86%	0.86%	0.78%	0.79%	0.75%	1.13%	0.14%

Athersys's average Quarter revenue forecast for Sep 23 based on 6 analysts is $61.25K, with a low forecast of $61.25K, and a high forecast of $61.25K. ATHX's average Quarter revenue forecast represents a 25.00% increase compared to the company's last Quarter revenue of $49.00K (Jun 23).

Athersys EBITDA Forecast

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Mar 18	Sep 17	Jun 17	Mar 17	Sep 16	Jun 16	Mar 16	Sep 15	Jun 15
# Analysts	7	6	6	6	6	13	6	13	20	9	9	10	9	9	9	9	9	8	8	8	9	9	9	9	9	8	8	8	9	9
EBITDA	-	-	-	-	$-7.78M	$-12.99M	$-7.28M	$-16.10M	$-23.64M	$-22.13M	$65.30M	$-15.76K	$-21.88M	$-26.22M	$-22.31M	$-18.15M	$-15.45M	$-11.85M	$-9.53M	$-12.77M	$-9.54M	$-9.97M	$-7.08M	$-6.11M	$-5.48M	$-5.90M	$-6.90M	$4.81M	$-6.46M	$-969.00K
Avg Forecast	$-110.25K	$-98.00K	$-85.75K	$-73.50K	$-61.25K	$-49.00K	$-120.00K	$-21.18K	$-15.32M	$-24.17M	$-40.00K	$-19.26K	$-16.39M	$-16.10M	$-17.35M	$-13.61M	$-11.68M	$-13.16M	$-12.71M	$-9.12M	$-9.54M	$-9.97M	$-7.08M	$-6.99M	$-6.26M	$-7.21M	$-8.28M	$11.90M	$-5.54M	$-1.62M
High Forecast	$-110.25K	$-98.00K	$-85.75K	$-73.50K	$-61.25K	$-49.00K	$-120.00K	$-16.95K	$-12.26M	$-19.33M	$-40.00K	$-15.41K	$-13.11M	$-12.88M	$-13.88M	$-10.89M	$-9.34M	$-10.53M	$-10.17M	$-7.30M	$-7.63M	$-7.98M	$-5.67M	$-5.59M	$-5.01M	$-5.77M	$-6.63M	$14.28M	$-4.43M	$-1.30M
Low Forecast	$-110.25K	$-98.00K	$-85.75K	$-73.50K	$-61.25K	$-49.00K	$-120.00K	$-25.42K	$-18.39M	$-29.00M	$-40.00K	$-23.11K	$-19.66M	$-19.32M	$-20.82M	$-16.34M	$-14.01M	$-15.80M	$-15.25M	$-10.95M	$-11.45M	$-11.96M	$-8.50M	$-8.38M	$-7.52M	$-8.66M	$-9.94M	$9.52M	$-6.64M	$-1.94M
Surprise %	-	-	-	-	127.02%	265.06%	60.68%	759.82%	1.54%	0.92%	-1632.40%	0.82%	1.33%	1.63%	1.29%	1.33%	1.32%	0.90%	0.75%	1.40%	1.00%	1.00%	1.00%	0.88%	0.88%	0.82%	0.83%	0.40%	1.17%	0.60%

9 analysts predict ATHX's average Quarter EBITDA for Mar 22 to be $-24.17M, with a high of $-19.33M and a low of $-29.00M. This is -137.01% lower than Athersys's previous annual EBITDA (Dec 21) of $65.30M.

Athersys Net Income Forecast

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Mar 18	Sep 17	Jun 17	Mar 17	Sep 16	Jun 16	Mar 16	Sep 15	Jun 15
# Analysts	7	6	6	6	6	13	6	13	20	9	9	10	9	9	9	9	9	8	8	8	9	9	9	9	9	8	8	8	9	9
Net Income	-	-	-	-	$-3.77M	-	$-8.29M	$-10.63M	$-23.04M	$-22.05M	-	-	$-22.60M	$-26.47M	$-22.54M	$-18.37M	$-15.64M	$-12.02M	$-9.69M	$-12.96M	$-9.74M	$-10.15M	$-7.24M	$-6.27M	$-5.63M	$-6.00M	$-6.96M	$4.75M	$-6.50M	$-1.03M
Avg Forecast	$31.91M	$27.79M	$32.63M	$-4.14M	$-4.35M	$24.68M	$11.18M	$-40.57M	$-15.85M	$-24.44M	$-41.40M	$25.78M	$-16.95M	$-16.17M	$-17.53M	$-13.78M	$-11.73M	$-13.35M	$-12.92M	$-9.25M	$-9.74M	$-10.15M	$-7.24M	$-7.16M	$-6.44M	$-7.34M	$-8.35M	$11.76M	$-5.57M	$-1.73M
High Forecast	$31.91M	$27.79M	$32.63M	$-4.14M	$-4.35M	$24.68M	$11.18M	$-40.57M	$-12.68M	$-19.55M	$-41.40M	$25.78M	$-13.56M	$-12.94M	$-14.03M	$-11.02M	$-9.39M	$-10.68M	$-10.33M	$-7.40M	$-7.79M	$-8.12M	$-5.79M	$-5.73M	$-5.15M	$-5.87M	$-6.68M	$14.11M	$-4.46M	$-1.38M
Low Forecast	$31.91M	$27.79M	$32.63M	$-4.14M	$-4.35M	$24.68M	$11.18M	$-40.57M	$-19.02M	$-29.33M	$-41.40M	$25.78M	$-20.34M	$-19.41M	$-21.04M	$-16.53M	$-14.08M	$-16.02M	$-15.50M	$-11.11M	$-11.69M	$-12.19M	$-8.69M	$-8.59M	$-7.72M	$-8.81M	$-10.02M	$9.40M	$-6.68M	$-2.08M
Surprise %	-	-	-	-	0.87%	-	-0.74%	0.26%	1.45%	0.90%	-	-	1.33%	1.64%	1.29%	1.33%	1.33%	0.90%	0.75%	1.40%	1.00%	1.00%	1.00%	0.88%	0.88%	0.82%	0.83%	0.40%	1.17%	0.60%

Athersys's average Quarter net income forecast for Jun 16 is $-8.35M, with a range of $-10.02M to $-6.68M. ATHX's average Quarter net income forecast represents a -275.73% decrease compared to the company's last Quarter net income of $4.75M (Mar 16).

Athersys SG&A Forecast

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Mar 18	Sep 17	Jun 17	Mar 17	Sep 16	Jun 16	Mar 16	Sep 15	Jun 15
# Analysts	7	6	6	6	6	13	6	13	20	9	9	10	9	9	9	9	9	8	8	8	9	9	9	9	9	8	8	8	9	9
SG&A	-	-	-	-	$2.81M	$2.35M	$2.81M	$3.74M	$5.16M	$4.10M	-	$3.63M	$4.16M	$8.84M	$3.70M	$4.43M	$3.47M	$2.96M	$2.87M	$3.11M	$2.56M	$2.65M	$2.11M	$2.21M	$2.07M	$1.83M	$1.99M	$2.01M	$1.94M	$1.92M
Avg Forecast	$97.90K	$87.02K	$76.14K	$65.27K	$54.39K	$43.51K	$106.56K	$39.07K	$33.21K	$2.84M	$35.52K	$35.52K	$35.52K	$372.95K	$59.40K	$59.67K	$339.80K	$360.63K	$3.82M	$997.99K	$2.06M	$950.14K	$355.19K	$694.10K	$1.52M	$353.92K	$665.99K	$4.98M	$310.79K	$1.37M
High Forecast	$97.90K	$87.02K	$76.14K	$65.27K	$54.39K	$43.51K	$106.56K	$46.88K	$39.85K	$2.84M	$35.52K	$42.62K	$35.52K	$372.95K	$59.40K	$59.67K	$339.80K	$360.63K	$4.59M	$997.99K	$2.06M	$950.14K	$355.19K	$694.10K	$1.52M	$353.92K	$665.99K	$5.98M	$310.79K	$1.37M
Low Forecast	$97.90K	$87.02K	$76.14K	$65.27K	$54.39K	$43.51K	$106.56K	$31.26K	$26.57K	$2.84M	$35.52K	$28.41K	$35.52K	$372.95K	$59.40K	$59.67K	$339.80K	$360.63K	$3.06M	$997.99K	$2.06M	$950.14K	$355.19K	$694.10K	$1.52M	$353.92K	$665.99K	$3.99M	$310.79K	$1.37M
Surprise %	-	-	-	-	51.63%	53.89%	26.42%	95.65%	155.44%	1.44%	-	102.26%	117.06%	23.69%	62.29%	74.27%	10.22%	8.20%	0.75%	3.11%	1.24%	2.79%	5.95%	3.18%	1.36%	5.17%	2.98%	0.40%	6.25%	1.41%

Athersys's average Quarter SG&A projection for Dec 23 is $65.27K, based on 6 Wall Street analysts, with a range of $65.27K to $65.27K. The forecast indicates a -97.68% fall compared to ATHX last annual SG&A of $2.81M (Sep 23).

Athersys EPS Forecast

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Mar 18	Sep 17	Jun 17	Mar 17	Sep 16	Jun 16	Mar 16	Sep 15	Jun 15
# Analysts	7	6	6	6	6	13	6	13	20	9	9	10	9	9	9	9	9	8	8	8	9	9	9	9	9	8	8	8	9	9
EPS	-	-	-	-	$-0.15	-	$-0.45	$-0.90	$-0.09	$-0.09	-	$-0.07	$-0.10	$-3.18	$-0.11	$-2.40	$-0.10	$-1.96	$-0.06	$-0.09	$-0.07	$-0.08	$-0.06	$-0.06	$-0.06	$-0.07	$-0.08	$0.06	$-0.08	$-0.01
Avg Forecast	$1.54	$1.34	$1.58	$-0.20	$-0.21	$1.19	$0.54	$-1.96	$-1.75	$-0.10	$-2.00	$1.25	$-2.00	$-2.00	$-2.00	$-2.00	$-2.00	$-2.00	$-0.09	$-0.07	$-2.00	$-2.50	$-1.50	$-1.50	$-1.75	$-2.75	$-2.50	$-1.75	$-1.75	$-2.00
High Forecast	$1.54	$1.34	$1.58	$-0.20	$-0.21	$1.19	$0.54	$-1.96	$-1.75	$-0.10	$-2.00	$1.25	$-2.00	$-2.00	$-2.00	$-2.00	$-2.00	$-2.00	$-0.09	$-0.07	$-2.00	$-2.50	$-1.50	$-1.50	$-1.75	$-2.75	$-2.50	$-1.75	$-1.75	$-2.00
Low Forecast	$1.54	$1.34	$1.58	$-0.20	$-0.21	$1.19	$0.54	$-1.96	$-1.75	$-0.10	$-2.00	$1.25	$-2.00	$-2.00	$-2.00	$-2.00	$-2.00	$-2.00	$-0.09	$-0.07	$-2.00	$-2.50	$-1.50	$-1.50	$-1.75	$-2.75	$-2.50	$-1.75	$-1.75	$-2.00
Surprise %	-	-	-	-	0.71%	-	-0.83%	0.46%	0.05%	0.90%	-	-0.06%	0.05%	1.59%	0.06%	1.20%	0.05%	0.98%	0.67%	1.29%	0.04%	0.03%	0.04%	0.04%	0.03%	0.03%	0.03%	-0.03%	0.05%	0.01%

According to 8 Wall Street analysts, Athersys's projected average Quarter EPS for Jun 16 is $-2.50, with a low estimate of $-2.50 and a high estimate of $-2.50. This represents a -4266.67% decrease compared to ATHX previous annual EPS of $0.06 (Mar 16).

Athersys Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ATHX	Athersys	$0.10	$5.00	4900.00%	Buy
ELEV	Elevation Oncology	$0.58	$9.00	1451.72%	Buy
RVPH	Reviva Pharmaceuticals	$1.26	$10.00	693.65%	Buy
ATXI	Avenue Therapeutics	$1.97	$12.00	509.14%	Buy
CKPT	Checkpoint Therapeutics	$3.38	$20.00	491.72%	Buy
AKBA	Akebia Therapeutics	$1.82	$6.50	257.14%	Buy
ZURA	Zura Bio	$3.15	$10.00	217.46%	Buy
PYXS	Pyxis Oncology	$4.16	$9.00	116.35%	Buy
TRVN	Trevena	$1.70	$3.50	105.88%	-
ETON	Eton Pharmaceuticals	$10.50	$13.00	23.81%	Buy
EFTR	eFFECTOR Therapeutics	-	$5.50	-	Buy

ATHX Forecast FAQ

Is Athersys a good buy?

Yes, according to 10 Wall Street analysts, Athersys (ATHX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 90.00% of ATHX's total ratings.

What are Athersys's analysts' financial forecasts?

ATHX's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $303.75K (high $303.75K, low $303.75K), average EBITDA is $-304K (high $-304K, low $-304K), average net income is $27.37M (high $27.37M, low $27.37M), average SG&A $269.72K (high $269.72K, low $269.72K), and average EPS is $1.32 (high $1.32, low $1.32).

Did the ATHX's actual financial results beat the analysts' financial forecasts?

Based on Athersys's last annual report (Dec 2021), the company's revenue was $5.51M, beating the average analysts forecast of $540K by 920.09%. Apple's EBITDA was $-85.631M, beating the average prediction of $-32.546M by 163.11%. The company's net income was $-172M, beating the average estimation of $-48.746M by 253.66%. Apple's SG&A was $20.06M, beating the average forecast of $479.51K by 4084.50%. Lastly, the company's EPS was $-19.22, beating the average prediction of $-4.755 by 304.23%. In terms of the last quarterly report (Jun 2023), Athersys's revenue was $49K, beating the average analysts' forecast of $49K by 0%. The company's EBITDA was $-12.988M, beating the average prediction of $-49K by 26406.12%. Athersys's net income was $0, missing the average estimation of $24.68M by -100.00%. The company's SG&A was $2.34M, beating the average forecast of $43.51K by 5289.44%. Lastly, the company's EPS was $0, missing the average prediction of $1.19 by -100.00%